Seelos Therapeutics Cost of Goods Sold (% of Quarterly Revenues) Analysis

Seelos Therapeutics Inc (SEELQ)

0.3249 -0.02 (-4.44%) USD | OTCM | Dec 19, 10:31

Cost of Goods Sold (% of Quarterly Revenues) Chart

View Cost of Goods Sold (% of Quarterly Revenues) for SEELQ.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Cost of Goods Sold (% of Quarterly Revenues) Chart

Start Trial

Historical Data

View Historical Data

Start Trial

Cost of Goods Sold Definition

View Cost of Goods Sold Definition

Start Trial

Cost of Goods Sold (COGS) is the measure of direct costs related to the production of goods. Includes the cost of obtaining raw materials and direct labor costs.

Read full definition.

Cost of Goods Sold (% of Quarterly Revenues) Range, Past 5 Years

View Cost of Goods Sold (% of Quarterly Revenues) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

Cost of Goods Sold (% of Quarterly Revenues) Benchmarks

View Cost of Goods Sold (% of Quarterly Revenues) Benchmarks

Start Trial

Cassava Sciences Inc	--
Bristol-Myers Squibb Co	Upgrade
enVVeno Medical Corp	--
NovaBay Pharmaceuticals Inc	Upgrade
Palatin Technologies Inc	--